- Home
- MDGL vs TIGO Comparison
MDGL vs TIGO Comparison
Compare MDGL & TIGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDGL
- TIGO
- Stock Information
- Founded
- MDGL 2011
- TIGO 1990
- Country
- MDGL United States
- TIGO Luxembourg
- Employees
- MDGL N/A
- TIGO N/A
- Industry
- MDGL Biotechnology: Pharmaceutical Preparations
- TIGO Telecommunications Equipment
- Sector
- MDGL Health Care
- TIGO Telecommunications
- Exchange
- MDGL Nasdaq
- TIGO Nasdaq
- Market Cap
- MDGL 6.1B
- TIGO 6.4B
- IPO Year
- MDGL N/A
- TIGO 1994
- Fundamental
- Price
- MDGL $304.86
- TIGO $37.34
- Analyst Decision
- MDGL Strong Buy
- TIGO Buy
- Analyst Count
- MDGL 9
- TIGO 6
- Target Price
- MDGL $420.63
- TIGO $38.90
- AVG Volume (30 Days)
- MDGL 305.4K
- TIGO 1.0M
- Earning Date
- MDGL 08-06-2025
- TIGO 08-07-2025
- Dividend Yield
- MDGL N/A
- TIGO 8.01%
- EPS Growth
- MDGL N/A
- TIGO 5635.24
- EPS
- MDGL N/A
- TIGO 2.06
- Revenue
- MDGL $317,383,000.00
- TIGO $5,691,000,000.00
- Revenue This Year
- MDGL $286.17
- TIGO N/A
- Revenue Next Year
- MDGL $64.17
- TIGO $2.39
- P/E Ratio
- MDGL N/A
- TIGO $17.47
- Revenue Growth
- MDGL N/A
- TIGO N/A
- 52 Week Low
- MDGL $200.63
- TIGO $23.61
- 52 Week High
- MDGL $377.46
- TIGO $38.50
- Technical
- Relative Strength Index (RSI)
- MDGL 61.70
- TIGO 48.07
- Support Level
- MDGL $277.64
- TIGO $35.62
- Resistance Level
- MDGL $314.22
- TIGO $38.33
- Average True Range (ATR)
- MDGL 11.62
- TIGO 0.94
- MACD
- MDGL 3.11
- TIGO -0.24
- Stochastic Oscillator
- MDGL 82.64
- TIGO 14.79
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
About TIGO Millicom International Cellular S.A.
Millicom offers wireless and fixed-line telecom services primarily in smaller, less developed countries in Latin America. Countries served include Bolivia (100% owned), Nicaragua (100%), Panama (100%), El Salvador (100%), Guatemala (100%), Paraguay (100%), Colombia (50%), and Honduras (67% but not controlled or consolidated in the firm's financial statements). The firm's wireless networks cover about 120 million people, serving 42 million customers. Its fixed-line networks reach 14 million homes, serving about 4 million broadband customers. Increasingly, Millicom offers converged packages that include broadband with wireless services. The firm has agreed to sell the majority of its wireless towers to SBA Communications for $975 million.